Dietmar Hoffmann, PhD

Director; Molecular, Expression and Screening Technologies (MEST), Sanofi Large Molecule Research 
Dietmar joined Aventis (acquired by Sanofi in 2004) in May 2002 at the Cambridge, US site. He currently leads a multidisciplinary team with 13 scientists within Sanofi’s Large Molecule Research Department (LMR) and is part of the Cambridge, US and extended, global LMR Leadership Team.  

His multidisciplinary team provides project teams across Sanofi R&D with Molecular Biology support and manages the Sanofi global plasmid repository. In addition, his team employs highly automated, robotic systems for high-throughput, protein & antibody expression and purification using mammalian cells as well as high-throughput screening of the expressed antibodies and proteins.